C4 Therapeutics(US:CCCC) Newsfilter·2024-07-08 11:00Core Insights - C4 Therapeutics (C4T) is a clinical-stage biopharmaceutical company focused on targeted protein degradation science to develop innovative medicines that can significantly improve patient outcomes [1][2]. Company Overview - C4T is advancing targeted oncology programs through clinical studies and utilizes its TORPEDO® platform to design and optimize small-molecule medicines aimed at challenging diseases [1][2]. - The company's degrader medicines aim to leverage the body's natural protein recycling system to effectively degrade disease-causing proteins, potentially addressing issues like drug resistance and undruggable targets [1]. Event Participation - C4T management will participate in a fireside chat at the UBS Targeted Protein Degradation (TPD) Day, scheduled for July 15, 2024 [2]. - A live webcast of the event will be available on the company's website, with an archived replay accessible for approximately 30 days post-event [4].